As agtech stocks fell behind the overall market, animal biotech and indoor farming companies showed two sides of that coin. On one, animal health specialists are riding the momentum of 2022 and demonstrating steady EBITDA growth. On the other, indoor farming is facing greater challenges as both public and private investors flee.
Our Q2 2023 Agtech Public Comp Sheet and Valuation Guide tracks stock performance, valuations, and market caps—as well as forecasts for revenue, EBITDA, and earnings per share—for key publicly traded companies.
|Free cash flow||11|
|Operating cash flow||13|
|Earnings per share||15|